WTO notificationSPSProposed measure, may since have been adoptedNew
Proposed measure from Peru: horses
Peru notified this proposed SPS measure to the WTO on 26 October 2026.
Symbol: G/SPS/N/PER/1138
WTO notification · TBT
PeruAdopted, according to its latest notice
Pharmaceutical products – Peru
Draft Supreme Decree amending articles of the Regulation governing the interchangeability of pharmaceutical products, approved by Supreme Decree No. 024-2018-SA.
View original
Proyecto de Decreto Supremo que modifica artículos del Reglamento que regula la intercambiabilidad de medicamentos, aprobado por Decreto Supremo N° 024-2018-SA.
Peru notified a revised version of this proposed TBT measure on 16 June 2026. The measure was first notified on 14 December 2015. The comment period closed on 15 August 2026.
Expodite puts notifications like this one in your Updates centre, matched to the HS codes of your products and the markets you export to. Opens the requirements check for Peru in your Expodite account.
Source: WTO ePing (opens in a new tab). Summaries by Expodite, which is independent of the WTO.
Published here:
Updated here:
At a glance
- Products
Pharmaceutical products: Medicines. Classified in chapter 30 of the Harmonized System or the Customs Tariff
View original
Productos farmacéuticos: Medicamentos. Clasificados en el capítulo 30 del Sistema Armonizado o el Arancel de Aduanas
- HS codes
- 30 · Pharmaceutical products
- 30
- 30 · Pharmaceutical products
- Notifying member
- Peru
- Status
- Adopted, according to its latest notice
- Objectives
- Protection of human health or safety
- Other
- Area
- TBT: Technical product rulesTechnical barriers to trade
- Notification type
- Regular notification
- Document symbol
- G/TBT/N/PER/82Latest notice: G/TBT/N/PER/82/Rev.1
- Keywords
- Human health
Key dates
- Distributed by the WTO
- Comment deadline
- Closed on 15 August 2026
- Proposed adoption
- To be determined
- Proposed entry into force
- A los seis (06) meses después de su publicación en el Diario Oficial El Peruano.
What the notification says
The notified draft Supreme Decree seeks to amend Articles 3, 4, 6, 10, 11, 12, 13, 16.1 and 17; the last paragraph of Article 22; Articles 23.3, 25, 26 and 27; and the first, second, fourth and seventh final supplementary provisions, of the Regulation on the interchangeability of medicines, approved by Supreme Decree No. 024-2018-SA. It also seeks to repeal the third final supplementary provision and to incorporate the tenth, eleventh and twelfth final supplementary provisions.G/TBT/N/PER/82/Rev.1- 2 -
Notices on this measure
Every notice about this measure published here, newest first. Each one is the notifying member's own text.
RevisionG/TBT/N/PER/82/Rev.1
Comment deadline: Closed on 15 August 2026
Draft Supreme Decree amending articles of the Regulation governing the interchangeability of pharmaceutical products, approved by Supreme Decree No. 024-2018-SA.
View original
Proyecto de Decreto Supremo que modifica artículos del Reglamento que regula la intercambiabilidad de medicamentos, aprobado por Decreto Supremo N° 024-2018-SA.
The notified draft Supreme Decree seeks to amend Articles 3, 4, 6, 10, 11, 12, 13, 16.1 and 17; the last paragraph of Article 22; Articles 23.3, 25, 26 and 27; and the first, second, fourth and seventh final supplementary provisions, of the Regulation on the interchangeability of medicines, approved by Supreme Decree No. 024-2018-SA. It also seeks to repeal the third final supplementary provision and to incorporate the tenth, eleventh and twelfth final supplementary provisions.G/TBT/N/PER/82/Rev.1- 2 -
AddendumG/TBT/N/PER/82/Add.1
Regulation on the interchangeability of medicines The Republic of Peru hereby advises that the final (definitive) version of the draft regulation on the interchangeability of medicines notified in document G/TBT/N/PER/82 of 14 December 2015 has been issued pursuant to Supreme Decree No. 024-2018-SA, published in the Official Journal El Peruano on 15 September 2018. It will enter into force six (6) months from the day after its publication.
Regular notificationG/TBT/N/PER/82
Comment deadline: Closed on 12 February 2016
Proyecto de Reglamento que regula la intercambiabilidad de medicamentos (Draft Regulation on the interchangeability of medicines) (16 pages, in Spanish);
The notified draft Regulation contains 4 titles, 26 articles, 12 final supplementary provisions and 1 annex, and establishes the regulatory provisions of Law No. 29459 - Law on pharmaceutical products, medical devices and sanitary products, in order to regulate the interchangeability of medicines.;
Sources
Expodite writes its summary from the official record. The notification and the documents it notifies are on the WTO's own websites.
More from Peru
All updates from PeruWTO notificationSPSProposed measure, open for commentsNew
Proposed measure from Peru: Seeds, fruit and spores; of a kind used for sowing
Peru notified this proposed SPS measure to the WTO on 23 October 2026. Comments are open until 22 December 2026.
Symbol: G/SPS/N/PER/1137Comments until 22 December 2026
WTO notificationSPSAdopted, according to its latest noticeNew
Adopted measure from Peru: Vegetables, leguminous
Peru issued an addendum on 23 October 2026 to the earlier SPS notification G/SPS/N/PER/1128. Addenda often report that a measure was adopted, changed, postponed or withdrawn. The measure was first notified on 22 May…
Symbol: G/SPS/N/PER/1128/Add.1Comment period closed
WTO notificationSPSAdopted, according to its latest noticeNew
Adopted measure from Peru: Vegetable products not elsewhere specified or included
Peru issued an addendum on 15 October 2026 to the earlier SPS notification G/SPS/N/PER/1112. Addenda often report that a measure was adopted, changed, postponed or withdrawn. The measure was first notified on 13 March…
Symbol: G/SPS/N/PER/1112/Add.1Comment period closed
Get these automatically for your products and markets.
Expodite matches each notification to the markets you export to and the HS codes of your products, and puts the ones that concern you in your Updates centre, with the date comments close.